NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Daan Biotherapeutics

Daan Biotherapeutics

Private
SeoulHealthcare & Life Scienceshttps://daanbiotpx.com/

Last Round

Series A

Jan 25, 2024

Est. Valuation

$20.5M

Total Funding Raised

$21.3M

Company Overview

Daan Biotherapeutics is a biotechnology company that develops treatments for cancer including cell therapies, antibodies, and small molecule inhibitors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

TCR-T cell therapysolid tumor treatmentantibody-drug conjugateADCcell therapyimmunotherapyimmuno-oncologyPRAME antigenT-cell engageroncology therapeuticssmall molecule inhibitorantibody discoveryclinical-stage biotechAttenTCR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Daan Biotherapeutics Comps

Public and private peers based on sector, stage, and business model.

Daan Biotherapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Daan Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 25, 2024
SeedMar 28, 2022

Daan Biotherapeutics Investors

Notable investors and investment history

Daan Biotherapeutics investors
InvestorRounds
Company K Partners, LimitedSeries A
DAYLI PartnersSeries A
Paratus InvestmentSeries A
KB InvestmentSeries A
Timefolio Asset ManagementSeed, Series A
Company K PartnersSeed
FuturePlaySeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 25, 2024

    $17M round led by Paratus Investment and Timefolio Asset Management.

  • Mar 28, 2022

    $4M round with participation from Timefolio Asset Management and Company K Partners.

Daan Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Daan Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Daan Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Year Founded2020
Last FundingJan 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.